Your browser doesn't support javascript.
loading
CDC25 as a common therapeutic target for triple-negative breast cancer - the challenges ahead.
Zacksenhaus, Eldad; Liu, Jeff C; Granieri, Letizia; Vorobieva, Ioulia; Wang, Dong-Yu; Ghanbari-Azarnier, Ronak; Li, Huiqin; Ali, Amjad; Chung, Philip E D; Ju, YoungJun; Jiang, Zhe; Shrestha, Mariusz.
Afiliação
  • Zacksenhaus E; Toronto General Research Institute - University Health Network, Toronto, Ontario, Canada.
  • Liu JC; Department of Laboratory Medicine & Pathobiology, University of Toronto, Toronto, Ontario, Canada.
  • Granieri L; Department of Medicine, University of Toronto, Toronto, Ontario, Canada.
  • Vorobieva I; Toronto General Research Institute - University Health Network, Toronto, Ontario, Canada.
  • Wang DY; Toronto General Research Institute - University Health Network, Toronto, Ontario, Canada.
  • Ghanbari-Azarnier R; European Institute of Oncology, Milan, Italy.
  • Li H; Toronto General Research Institute - University Health Network, Toronto, Ontario, Canada.
  • Ali A; Department of Laboratory Medicine & Pathobiology, University of Toronto, Toronto, Ontario, Canada.
  • Chung PED; Toronto General Research Institute - University Health Network, Toronto, Ontario, Canada.
  • Ju Y; Toronto General Research Institute - University Health Network, Toronto, Ontario, Canada.
  • Jiang Z; Department of Laboratory Medicine & Pathobiology, University of Toronto, Toronto, Ontario, Canada.
  • Shrestha M; Toronto General Research Institute - University Health Network, Toronto, Ontario, Canada.
Mol Cell Oncol ; 5(4): e1481814, 2018.
Article em En | MEDLINE | ID: mdl-30250928

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2018 Tipo de documento: Article